摘要
International Journal of DermatologyEarly View Letter to the Editor Successful treatment of porokeratosis ptychotropica with abrocitinib Xue Zhang, Corresponding Author Xue Zhang [email protected] orcid.org/0000-0002-0159-0263 Department of Dermatology, The Affiliated Chengdu 363 Hospital of Southwest Medical University, Chengdu, Sichuan, ChinaSearch for more papers by this authorYunjie Zhang, Yunjie Zhang Department of Dermatology, The Affiliated Chengdu 363 Hospital of Southwest Medical University, Chengdu, Sichuan, ChinaSearch for more papers by this authorChao Lv, Chao Lv Department of Dermatology, The Affiliated Chengdu 363 Hospital of Southwest Medical University, Chengdu, Sichuan, ChinaSearch for more papers by this authorQin Zou, Qin Zou Department of Dermatology, The Affiliated Chengdu 363 Hospital of Southwest Medical University, Chengdu, Sichuan, ChinaSearch for more papers by this authorKaihua Zhou, Kaihua Zhou Department of Dermatology, The Affiliated Chengdu 363 Hospital of Southwest Medical University, Chengdu, Sichuan, ChinaSearch for more papers by this author Xue Zhang, Corresponding Author Xue Zhang [email protected] orcid.org/0000-0002-0159-0263 Department of Dermatology, The Affiliated Chengdu 363 Hospital of Southwest Medical University, Chengdu, Sichuan, ChinaSearch for more papers by this authorYunjie Zhang, Yunjie Zhang Department of Dermatology, The Affiliated Chengdu 363 Hospital of Southwest Medical University, Chengdu, Sichuan, ChinaSearch for more papers by this authorChao Lv, Chao Lv Department of Dermatology, The Affiliated Chengdu 363 Hospital of Southwest Medical University, Chengdu, Sichuan, ChinaSearch for more papers by this authorQin Zou, Qin Zou Department of Dermatology, The Affiliated Chengdu 363 Hospital of Southwest Medical University, Chengdu, Sichuan, ChinaSearch for more papers by this authorKaihua Zhou, Kaihua Zhou Department of Dermatology, The Affiliated Chengdu 363 Hospital of Southwest Medical University, Chengdu, Sichuan, ChinaSearch for more papers by this author First published: 22 April 2024 https://doi.org/10.1111/ijd.17202 Conflict of interest: None. Funding source: None. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Joshi R, Minni K. Genitogluteal porokeratosis: a clinical review. Clin Cosmet Investig Dermatol. 2018; 11: 219–229. 10.2147/CCID.S143085 PubMedWeb of Science®Google Scholar 2Baltazar D, Shinamoto SR, Hamann CP, Hamann D, Hamann CR. Occupational airborne allergic contact dermatitis to invasive Compositae species treated with abrocitinib: a case report. Contact Derm. 2022; 87(6): 542–544. 10.1111/cod.14204 PubMedWeb of Science®Google Scholar 3Zhang L, Guo L, Wang L, Jiang X. The efficacy and safety of tofacitinib, peficitinib, solcitinib, baricitinib, abrocitinib and deucravacitinib in plaque psoriasis-A network meta-analysis. J Eur Acad Dermatol Venereol. 2022; 36: 1937–1946. 10.1111/jdv.18263 CASPubMedWeb of Science®Google Scholar 4Solimani F, Mesas-Fernández A, Dilling A, Nast A, Hilke FJ, Ghoreschi FC, et al. The Janus kinase 1 inhibitor abrocitinib for the treatment of oral lichen planus. J Eur Acad Dermatol Venereol. 2023; 37: e996–998. 10.1111/jdv.19069 CASGoogle Scholar 5Bai J, Su W, Fang H, Qiao J. Treatment of primary cutaneous lichenoid amyloidosis with abrocitinib: a pilot study in two cases. Int J Dermatol. 2023; 62: e480–e483. 10.1111/ijd.16698 PubMedGoogle Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation